Trial result ·
Effect of intensive blood pressure control on cognitive outcomes and brain structures in adults with type 2 diabetes: prespecified analysis of secondary outcomes of BPROAD randomised controlled trial.
Written based on 1 research study on PubMed, searched on 15 Nov 2026.
What was studied
This trial looked at people with type 2 diabetes and raised blood pressure. They were aged 50 or more and had a raised risk of heart disease. The study took place at 145 centres in China. In this part, 12 434 people without likely dementia took part. People were put into groups by chance. One group aimed for a top blood pressure number under 120. The other group aimed for under 140. Tests of memory and thinking were done each year. Some people also had brain scans, called MRI.
What they found
People were followed for a median of 3.8 years. Dementia or mild thinking problems arose in 747 people in the strict group. This happened to 783 people in the usual group. The gap between the groups was not statistically clear. In the scan part, 428 and 434 people were looked at. In the strict group, damaged areas in the white matter of the brain grew less.
What it means for patients
In this trial, a lower blood pressure target did not clearly change thinking outcomes. Rates of dementia or mild thinking problems were alike in both groups. The authors did link the strict target to less growth of white matter damage. This was seen on brain scans.
Why it is not certain yet
People and their doctors knew which group they were in. Only the people judging the results did not know. Brain scans were done in only a part of the group. At the start, 862 people had a scan, and 605 had a final scan. Follow-up was a median of 3.8 years. The abstract does not give results for changes in thinking test scores.
Source
Effect of intensive blood pressure control on cognitive outcomes and brain structures in adults with type 2 diabetes: prespecified analysis of secondary outcomes of BPROAD randomised controlled trial.
PubMed · PMID 43020520We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Mild cognitive impairment publications